Total Payments
$15,616
2024 Payments
$2,546
Companies
57
Transactions
572
Medicare Patients
286
Medicare Billing
$54,315
Payment Breakdown by Category
Food & Beverage$13,308 (85.2%)
Education$2,308 (14.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,308 | 547 | 85.2% |
| Education | $2,308 | 25 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,767 | 41 | $0 (2024) |
| Lilly USA, LLC | $1,065 | 42 | $0 (2024) |
| Seagen Inc. | $1,031 | 33 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $957.46 | 77 | $0 (2024) |
| Daiichi Sankyo Inc. | $886.85 | 33 | $0 (2024) |
| Incyte Corporation | $781.62 | 21 | $0 (2023) |
| Merck Sharp & Dohme LLC | $749.88 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $747.47 | 26 | $0 (2024) |
| PFIZER INC. | $691.15 | 31 | $0 (2024) |
| Celgene Corporation | $590.47 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,546 | 75 | AstraZeneca Pharmaceuticals LP ($480.24) |
| 2023 | $4,216 | 166 | AstraZeneca Pharmaceuticals LP ($478.61) |
| 2022 | $4,887 | 163 | Seagen Inc. ($603.36) |
| 2021 | $3,968 | 168 | Lilly USA, LLC ($357.82) |
All Payment Transactions
572 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 08/07/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Oncology | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.67 | General |
| 07/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Oncology | ||||||
| 06/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $28.46 | General |
| Category: Hematology | ||||||
| 06/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Oncology | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Oncology | ||||||
| 06/08/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Hematology | ||||||
| 06/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 59 | 148 | $45,840 | $10,173 |
| 2022 | 2 | 86 | 244 | $68,640 | $18,101 |
| 2021 | 1 | 64 | 197 | $62,843 | $15,141 |
| 2020 | 2 | 77 | 182 | $56,158 | $10,900 |
Total Patients
286
Total Services
771
Medicare Billing
$54,315
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 148 | $45,840 | $10,173 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 227 | $65,410 | $17,337 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 17 | $3,230 | $764.55 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 197 | $62,843 | $15,141 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 163 | $51,997 | $10,157 | 19.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 19 | $4,161 | $743.39 | 17.9% |
About Ami Lam
Ami Lam is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1558759670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ami Lam has received a total of $15,616 in payments from pharmaceutical and medical device companies, with $2,546 received in 2024. These payments were reported across 572 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,308).
As a Medicare-enrolled provider, Lam has provided services to 286 Medicare beneficiaries, totaling 771 services with total Medicare billing of $54,315. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 12/23/2014
- Last Updated 12/23/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558759670
Products in Payments
- TAGRISSO (Drug) $749.77
- KEYTRUDA (Biological) $723.32
- Enhertu (Drug) $691.86
- VERZENIO (Drug) $629.45
- OPDIVO (Biological) $584.09
- MONJUVI (Drug) $539.63
- Lenvima (Drug) $501.97
- IMFINZI (Biological) $441.91
- PROMACTA (Drug) $372.01
- REBLOZYL (Biological) $358.36
- NERLYNX (Drug) $327.18
- ERLEADA (Drug) $326.59
- TUKYSA (Drug) $323.85
- LIBTAYO (Biological) $315.98
- Empaveli (Drug) $263.62
- PADCEV (Biological) $253.99
- DARZALEX (Biological) $245.52
- XTANDI (Drug) $235.36
- Trodelvy (Drug) $220.92
- JEVTANA (Drug) $219.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Family $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Family $18,034
Seida Velija
Family — Payments: $15,903
Family $15,903
Christina Lao
Family — Payments: $15,127
Family $15,127
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415
Family $8,415
Lorraine Bertelle, Family Nurse Practit, FAMILY NURSE PRACTIT
Family — Payments: $7,053
Family $7,053